Sitravatinib and its Impurities

Sitravatinib (MGCD516) is an experimental drug for the treatment of cancer. It is a small molecule inhibitor of multiple tyrosine kinases. Reference standards of Sitravatinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.